This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Jun 25:zwaf364.

doi: 10.1093/eurjpc/zwaf364. Online ahead of print.

Metabolic Syndrome Adversely Impacts Mortality from Steatotic Liver disease

Robert S Rosenson¹, Jeffrey I Mechanick¹

Affiliations

PMID: 40557959
DOI: 10.1093/eurjpc/zwaf364

Editorial

Metabolic Syndrome Adversely Impacts Mortality from Steatotic Liver disease

Robert S Rosenson et al. Eur J Prev Cardiol. 2025.

. 2025 Jun 25:zwaf364.

doi: 10.1093/eurjpc/zwaf364. Online ahead of print.

Authors

Robert S Rosenson¹, Jeffrey I Mechanick¹

Affiliation

¹ Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

PMID: 40557959
DOI: 10.1093/eurjpc/zwaf364

No abstract available

PubMed Disclaimer

Comment on

Steatotic Liver Disease as a Risk Enhancer in the Presence of Metabolic Syndrome.
Zeng G, Wang P, Xu W, Li Q, Li T, Tian Y, Huang B, Grobbee D, Cabezas MC, Yuan J. Zeng G, et al. Eur J Prev Cardiol. 2025 Jun 12:zwaf330. doi: 10.1093/eurjpc/zwaf330. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 40501166

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems